Revascularization during acute myocardial infarction: risks and benefits revisited

Revascularization during acute myocardial infarction: risks and benefits revisited

Revascularization During Acute Myocardial Infarction: Risks and Benefits Revisited Johannes M. Albes, MD, Michael Gross, MD, Ulrich Franke, MD, Jens W...

149KB Sizes 0 Downloads 148 Views

Revascularization During Acute Myocardial Infarction: Risks and Benefits Revisited Johannes M. Albes, MD, Michael Gross, MD, Ulrich Franke, MD, Jens Wippermann, MD, Tina U. Cohnert, MD, Ru¨diger Vollandt, PhD, and Thorsten Wahlers, MD Departments of Cardiothoracic and Vascular Surgery and Medical Statistics, Informatics, and Documentation, Friedrich-SchillerUniversity Hospital Jena, Jena, Germany

Background. Indication for immediate revascularization during acute myocardial infarction (MI) is debated. Drug-resistant crescendo angina, as well as hemodynamic compromise, however, often requires acute operation. In this study the differential risks of acute coronary artery bypass grafting with and without MI were stratified. Methods. Five hundred eighteen patients undergoing isolated coronary artery bypass grafting were investigated. Thirty-nine patients underwent acute revascularization because of enzyme-proven or electrocardiogramproven MI accompanied by crescendo angina, hemodynamic compromise, or both. They were compared with 33 emergent, 63 urgent, and 383 elective patients without MI. Preoperative risk factors for early mortality and necessity of continuous venovenous hemofiltration were analyzed by means of logistical regression analysis. Perioperative data were compared. Results. Early mortality of the MI cohort was 15.4%, in contrast to 15.2% in emergent, none in urgent, and 2.1% in elective patients. Left internal thoracic artery was used in 87% of MI, 97% of emergent, 94% of urgent, and 97%

of elective patients. Intraaortic balloon pump was necessary in 50% of MI patients, 27% of emergent, 6.3% of urgent, and 3.1% of elective cases. Continuous venovenous hemofiltration was performed in 29% of MI patients, 15% of emergent, 4.9% of urgent, and 3.4% of elective patients. Hemodynamic instability significantly increased the odds ratio for early mortality and continuous venovenous hemofiltration. Conclusions. Patients undergoing acute revascularization carried an elevated risk to die early notwithstanding the presence or absence of acute MI. Liberal use of left internal thoracic artery grafts was not detrimental in acute patients whereas liberal use of intraaortic balloon pump was beneficial. In almost 30% of MI patients, continuous venovenous hemofiltration was not necessary, implying a severely impaired perioperative hemodynamic condition. Immediate revascularization in the presence of acute MI is therefore indicated although it may be addressed as a separate high-risk group.

T

an unclear myocardial state as well as often unknown comorbidities [4]. Furthermore, potent platelet aggregation inhibitor application or even fibrinolytic therapy directly before surgical intervention may cause additional problems [5]. Although the sequelae of these measures can be managed by means of blood products and antifibrinolytic agents, recent studies suggest that myocardial free wall rupture can be caused or aggravated by fibrinolytic agents [6]. Surgical intervention during acute infarction is risky. In the review of the literature, early mortality (EM) rates of more than 30% are not unusual [7]. However, as the spontaneous course of these patients is poor, acute intervention has repeatedly been recommended [8]. Surprisingly, little insight has been achieved so far regarding a differential analysis of the acute revascularization. While we encountered an increasing number of patients who had to be operated on in the presence of an ongoing infarction, a retrospective short-term analysis was conducted to disclose potential differences of acutely revascularized patients with or without acute MI.

he benefit of an acute restoration of uncompromised blood flow in the coronary arteries is clear [1]. Several studies show an improved postinterventional course after acute percutaneous transluminal coronary angioplasty (PTCA) with or without stenting in these patients [2]. However, the rising numbers of instantaneous interventions for acute myocardial infarction (MI) have resulted in an increasing demand for immediate surgical procedures in patients who do not technically qualify for a catheter intervention or in patients in whom this measure fails [3]. Acute surgical intervention in the presence of drug-resistant crescendo angina or even hemodynamic compromise during acute MI has been extensively debated. However, recent data show that immediate revascularization of such a cohort can indeed be beneficial [3], although the surgeon has to cope with

Accepted for publication March 19, 2002. Address reprint requests to Dr Albes, Department of Cardiothoracic and Vascular Surgery, University Hospital Jena, Jena 07740, Germany; e-mail: [email protected].

© 2002 by The Society of Thoracic Surgeons Published by Elsevier Science Inc

(Ann Thorac Surg 2002;74:102– 8) © 2002 by The Society of Thoracic Surgeons

0003-4975/02/$22.00 PII S0003-4975(02)03611-1

Ann Thorac Surg 2002;74:102– 8

Patients and Methods From January 2000 until May 2001, 518 patients underwent isolated operation for coronary artery disease and were retrospectively analyzed. The operative procedure was performed by means of standard extracorporeal circulation using mild hypothermia (30° to 32°C) and central arterial and two-stage venous cannulation, as well as cardioplegic arrest (4°C) with blood or crystalloid cardioplegia. Thirty-nine patients who underwent acute revascularization while suffering from acute MI and who exhibited drug-resistant crescendo angina, hemodynamic compromise, or both were compared with 33 emergently revascularized patients without acute MI, 63 urgent cases, and 383 elective patients. Myocardial infarction and emergent revascularization were defined when patients were directly transferred from the catheter laboratory to the operating theater. Owing to specific regional characteristics of our hospital, which is located in a rural area with a variety of small external referring catheter laboratories, the transferral time frame occasionally exceeded 6 hours. Urgent revascularization was defined when the operation was performed within 48 hours after invasive diagnosis whereas all other patients were defined as elective cases. Acute MI was proven by means of respective electrocardiogram alterations (pathologic Q-wave, S-T elevation, T-wave alteration) or a significant (minimum 10-fold) increase of initial postoperative (⬍20 minutes) troponin I [9, 10], as well as significant creatine kinase isoenzyme (CK-MB) serum levels. Preoperative risk factors were obtained. Preoperative hemodynamic stability status was assessed at anesthesia, and patients were stratified into three groups: stable— conscious, no hypotension, no inotropic support; unstable— hypotension, low cardiac output, necessity of inotropic support; resuscitation—necessity of resuscitation in the operating theater. Preoperative intraaortic balloon pump (IABP) was not used in the acute patients. Complete revascularization as well as the use of the left internal thoracic artery (LITA) was the operative aim. Therefore, LITA was occasionally prepared after emergent institution of extracorporeal circulation. Indication for continuous venovenous hemofiltration (CVVH) was made clinically with respect to the expected course of renal function: Severe decrease of urine production to less than 0.5 mL/kg per day (30 to 50 mL/h) despite high-dose furosemide support (⬎1 g/d) was accompanied by massive fluid overload (central venous pressure of ⬎18 mm Hg) or subsequent serum potassium levels of more than 6.5 mmol/L. An IABP was implanted intraoperatively when cardiac output appeared to be inadequate. An 8F balloon catheter was percutaneously advanced by means of the femoral artery without a sheath. Indication for extracorporeal membrane oxygenation was made on a highly individual basis: persistent low cardiac output accompanied by lactate increase under appropriate catecholamine support when an IABP was already in place. Type of cardioplegia, number and type of grafts, necessity of IABP, extracorporeal membrane oxygenation, necessity of temporary or permanent CVVH, hos-

ALBES ET AL ACUTE REVASCULARIZATION

103

pitalization, EM, Cleveland-Score, and EuroSCORE were assessed and statistically compared among all groups. Cleveland-Score and EuroSCORE were used for operative risk assessment. Both scores are validated risk scores [11, 12] for cardiac procedures comprising comorbidities, demographic data, cardiac function, and previous cardiac procedures. Statistical analysis was performed using SPSS statistical package (SPSS Inc, Chicago, IL) for Windows (Microsoft Inc, Seattle, WA). Numeric variables with normal distribution were analyzed by means of analysis of variance and post hoc comparisons with Tukey-HSD (honestly significant difference) adjustment. Nonnormally distributed variables were analyzed by means of Kruskal-Wallis test and subsequent Mann-Whitney U test. Categorical variables were analyzed by means of Pearson ␹2 test with ␣ adjustment. Logistical regression analysis of preoperative risk factors was performed to assess the odds ratio for EM and necessity of CVVH. Data are shown as mean percentages or means ⫾ standard deviation (SD). Odds ratios are presented with 95% confidence intervals. Significance was assumed if p was ⬍0.05. Analysis of variance, Kruskal-Wallis, or Pearson ␹2 test p values or Student’s t test or Mann-Whitney U test p values between specific groups are shown.

Results Demographic Data Age did not differ significantly among the four groups although the elective patients tended to be younger than the other three groups. In the MI and the emergent group a higher but not statistically significant proportion was female. The majority of the patients were obese. A typical proportion of diabetes and chronic obstructive pulmonary disease was present in all groups. The acuity in both immediate groups was reflected by a higher mean New York Heart Association class accompanied by reduced left ventricular function (Table 1).

Preoperative Therapy of Acute Patients In the MI group 14 patients (36%) underwent isolated PTCA, 3 patients (8%) underwent fibrinolytic therapy alone; in another 3 patients fibrinolytic therapy and PTCA was performed, and 10 patients (26%) received potent platelet aggregation inhibitors, such as glycoprotein IIb-IIIa–receptor antagonists. Percutaneous transluminal coronary angioplasty was considered to be successful in 6 (15%) of the acute patients although referral to the cardiac surgeon was initiated according to the above-mentioned criteria. In contrast, primary PTCA failure occurred in 8 (21%) of these patients. Eleven (28%) of the patients were directly transferred after diagnostic catheterization without therapeutic measures.

Troponin and Cardiac Enzymes The patients suffering from acute MI showed the highest initial peak serum troponin I and CK-MB levels (troponin I, 32.7 ⫾ 37.6 ng/mL [normal range, 0.1 ng/mL]; CK-MB,

104

ALBES ET AL ACUTE REVASCULARIZATION

Ann Thorac Surg 2002;74:102– 8

Table 1. Demographic Data and Characteristics of Study Groups Variable Age (y) Sex (%) Body mass index COPD (%) Diabetes mellitus (%) Serum creatinine level (mmol/L) NYHA functional class III or IV (%) No. of stenotic arteries One Two Three LVEF (%) a

Emergent vs. elective.

b

MI

Emergent

Urgent

Elective

p Value

67 ⫾ 10 69.2 26.4 ⫾ 9.8 16.1 23.5 103.6 ⫾ 54.5 95

69 ⫾ 8 69.7 27.0 ⫾ 3.4 23.1 26.9 89.9 ⫾ 26.2 87.5

68 ⫾ 8 79.4 27.2 ⫾ 3.4 12.5 35.7 99.6 ⫾ 51.3 77.2

65 ⫾ 10 80.2 27.5 ⫾ 3.9 13.0 35.7 107.8 ⫾ 87.3 75.6

0.088a 0.246 0.544 0.264 0.553 0.654 ⬍0.001 0.118

9.5 19.0 81.5 42.0 ⫾ 16.5

0 18.8 81.3 50.6 ⫾ 15.8

0 9.5 90.5 52.6 ⫾ 22.0

5.0 11.5 83.6 57.0 ⫾ 18.0

0.004b

MI vs. elective.

COPD ⫽ chronic obstructive pulmonary disease; Heart Association.

LVEF ⫽ left ventricular ejection fraction;

1.58 ⫾ 1.28 ␮mol/L ⫻ s [normal range, 0.16 ␮mol/L ⫻ s]. In the emergent cohort, troponin I levels and CK-MB levels were lower than in the acute group but higher than in the urgent cohort (troponin I, 2.02 ⫾ 3.9 ng/mL; CK-MB, 0.29 ⫾ 0.24 ␮mol/L ⫻ s). In the urgent group, troponin I levels were slightly elevated (troponin I, 0,91 ⫾ 1.03 ng/mL; CK-MB, 0.21 ⫾ 0.13 ␮mol/L ⫻ s). The differences of troponin I and CK-MB among the MI and both the emergent and urgent groups were statistically significant (p ⬍ 0.001), whereas the observed differences between emergent and urgent patients did not exhibit statistical significance.

Type of Cardioplegia All but one of the MI and the emergent patients, respectively, received cold blood cardioplegia (96%; 95%) in contrast to 61% of the urgent patients and 47% of the elective patients. The remaining patients received crystalloid cardioplegia.

MI ⫽ myocardial infarction;

NYHA ⫽ New York

emergent group exhibited statistical differences compared with urgent and elective cases whereas no statistical difference was apparent between urgent and elective patients. No morbidity, such as perforation of the iliac artery or aorta or hypoperfusion of the ipsilateral or contralateral extremity, was detected (Table 2).

Extracorporeal Membrane Oxygenation Extracorporeal membrane oxygenation was instituted in one instance in all groups. The elective as well as the MI patient died, whereas the 2 patients of the urgent and the emergent groups survived (Table 2).

Continuous Venovenous Hemofiltration

The majority of all patients received a LITA graft to the left anterior descending artery. Although in the MI group the percentage was lower than in the other groups, the difference was only significant when compared with the elective patients. Ninety-two (24%) of the elective patients received more than one artery (LITA, right internal thoracic artery, or radial artery); in 62 (16%) of the elective cases the revascularization was entirely arterial. Because of the higher number of total arterial revascularizations, the average number of venous anastomoses in the elective group was significantly lower than in all other groups (Table 2).

Use of CVVH was necessary in 28.2% of MI patients, 15.2% of emergent cases, 4.8% of urgent patients, and 3.2% of elective patients. Three of the 11 patients in the MI group died, 4 of the 5 patients in the emergent groups died, whereas none of the urgent and 5 of the 12 patients in the elective cohort died. The differences between the total number of CVVH of the MI and the emergent patients were statistically significant when compared with the total number of urgent as well as elective cases, whereas no statistically significant differences were seen between MI and emergent as well as between urgent and elective patients. Hemofiltration became permanent in 10% of the MI group, 9% of emergent patients, 5% of the urgent cohort, and 1.6% of elective cases (Table 2). Female sex, age, urgency status, and stability significantly affected the odds ratio for the necessity of postoperative CVVH whereas preoperative serum creatinine or compensated renal function did not show a significant increase (Table 3).

Intraaortic Balloon Pumping

Early Mortality

Intraaortic balloon pumping was used in 50% of MI patients, 27% of emergent cases, 6.3% of urgent patients, and 3.1% of elective patients. The percentage of IABP in the MI group differed significantly from urgent and elective patients but not from the emergent cohort. The

Early mortality of the MI group was 15.4%, whereas it was 15.2% in the emergent cohort. None of the urgent patients died, whereas 2.1% of the elective patients died early. Both immediate groups exhibited significant differences when compared with urgent as well as elective

Number and Type of Grafts

Ann Thorac Surg 2002;74:102– 8

ALBES ET AL ACUTE REVASCULARIZATION

105

Table 2. Perioperative Data of Study Groups Variable

MI

Emergent

Urgent

Elective

p Value

IABP (%)

50

27.3

6.3

3.1

28.2

15.2

4.8

3.2

⬍0.001a ⬍0.001b 0.774c 0.303d ⬍0.001e 0.043f 0.01g 0.99c

CVVH (%)

Temporary Permanent ECMO (n) Blood cardiolegia (%) LITA (%) No. of vein grafts (n) Early mortality Cleveland-Score

17.9 10.3 1 96 87.2 2.3 ⫾ 1.5 15.4 7.7 ⫾ 2.7

6.1 9.1 1 95 97.1 2.4 ⫾ 1.0 15.2 6.3 ⫾ 3.3

4.8 1 61 93.7 2.4 ⫾ 1.4 0 2.6 ⫾ 2.7

1.6 1.6 1 47 97.1 1.9 ⫾ 0.5 2.1 2.1 ⫾ 2.4

Euro-SCORE

9.5 ⫾ 3.4

8.1 ⫾ 3.1

5.3 ⫾ 2.6

4.6 ⫾ 2.8

a MI vs. all other groups; f tive. Emergent vs. urgent.

b

⬍0.001h 0.008i 0.032 ⬍0.001 0.067d ⬍0.001h 0.336c 0.585d ⬍0.001h 0.511c

c d e Emergent vs. urgent and elective. Urgent vs. elective. MI vs. emergent. MI vs. urgent and elecg h i Emergent vs. elective. MI and emergent vs. urgent and elective. MI vs. elective.

CVVH ⫽ continuous venovenous hemofiltration; ECMO ⫽ extracorporeal membrane oxygenation; LITA ⫽ left internal thoracic artery; MI ⫽ myocardial infarction.-

patients (Table 2). Female sex, age, and obesity increased the odds ratio for EM moderately. In contrast, urgency and stability status, as well as preoperative renal impairment, markedly increased the odds ratio to die early, whereas other factors, such as chronic obstructive pulmonary disease or cerebrovascular disease, did not show statistical effects (Table 4).

Scores Cleveland-Score as well as EuroSCORE revealed the highest values in the MI group followed by emergent patients. Both groups showed distinct differences from both the urgent and the elective groups. Whereas Cleveland-Score exhibited a trend toward a differentiation between MI and acute patients, this distinction was not seen in the EuroSCORE (Table 2, Fig 1).

Comment While the total number of cardiologic interventions world-wide increases, the indication as well as the complexity of interventional strategies have been expanded. Patient selection for coronary surgical procedures has therefore been shifted toward more complex cases exhibiting considerable comorbidities [13]. In urgent or acute patients these underlying factors accumulate unfavorably with the particular problems of the emergent situation [14]. Markedly elevated risks are inevitable consequences. Although it has been proven that fibrinolytic therapy and antiplatelet aggregation measures with or

IABP ⫽ intraaortic balloon pumping;

without PTCA are beneficial in acute MI, patients are referred to the surgeon when these measures do not generate the desired results [15]. The surgeon is then confronted with a patient in an unstable hemodynamic situation accompanied by comorbidities, which are often improperly elucidated, and must reckon with a deranged coagulation system [4]. For many years studies using the huge numbers of coronary artery bypass grafting could demonstrate distinct differences in the outcome of patients stratified into typical risk groups with regard to the urgency of surgical intervention. It was demonstrated that urgent, emergent, or elective revascularization significantly affects EM and morbidity, as well as late mortality [16]. Reinecke and colleagues [4] compared historic data with recent results of acute coronary artery bypass grafting and revealed a risk progression of emergency coronary artery bypass grafting as a consequence of increasing comorbidities. Several authors have already analyzed emergent revascularization after failed PTCA and reported that it consistently showed an EM between 10% and 15%. Unfortunately, the presence of acute MI has not been assessed differentially in these studies [4, 13, 17]. In our study, electrocardiogram alterations served as one of the two indicators for acute MI. These were mainly S-T elevations or pathologic Q waves. Because of the rapidly changing electrocardiogram pattern during the evolving phase of acute MI, a differential analysis on the basis of electrocardiogram findings was not performed. Troponin I as well as CK-MB levels were used for further

106

ALBES ET AL ACUTE REVASCULARIZATION

Ann Thorac Surg 2002;74:102– 8

Table 3. Multivariate Risk Model for Early Mortality Variable

Odds Ratio

Female sex Age Body mass index 25–27 ⬍25 ⬎27 Urgency Elective Urgent Emergent MI Stability (stable vs. unstable and resuscitation) Diseased vessels Single/double vs. triple Serum creatinine (mmol/L) 50 –110 111–300 ⬎300 Renal function Normal Compensated Terminal COPD Cerebrovascular disease COPD ⫽ chronic obstructive pulmonary disease;

95% Confidence Interval

p Value

2.796 1.065

(1.096 –7.129) (1.007–1.127)

0.031 0.028

Reference 0.513 0.305

(0.145–1.811) (0.094 – 0.987)

0.135 0.299 0.047

Reference 0.002 8.371 8.523 6.736

(0.000 –7.214 ⫻ 10⫺14) (2.568 –27.281) (2.790 –26.036) (2.040 –22.240)

2.568

0.000 0.759 ⬍0.001 ⬍0.001 0.002

(0.331–19.906)

0.361

Reference 1.843 0.008

(0.631–5.383) (0.000 –5.593 ⫻ 10⫺12)

0.514 0.264 0.781

Reference 3.101 4.381 2.078 1.068

0.060 (1.124 – 8.554) (0.500 –38.343) (0.655– 6.594) (0.136 – 8.377)

0.029 0.182 0.214 0.951

MI ⫽ myocardial infarction.

verification of acute MI. The observed differences were therefore expected. Surprisingly, however, emergent patients also exhibited higher values than the urgent group. This may point to some acute but minor myocardial damage in the emergent cohort. Our findings support the theory that ischemia cannot necessarily be separated sharply from cellular damage [18, 19]. A substantial number of acute MI patients were transferred to our unit without interventional or therapeutic measures. In our rural area we cooperate with several cardiologists working in small units, who are not as aggressive as the colleagues of a large university center. We used blood cardioplegia in nearly all emergent situations and also in the majority of the urgent cases. Owing to financial reasons, however, crystalloid cardioplegia was used in half of the elective cases. Cold-blood cardioplegia has been unequivocally recommended as a sufficient myocardial protective agent [20]. Because blood cardioplegia was mainly used, both immediate groups received the most homogeneous and optimal myocardial protection measures of all four groups of our study. Therefore, inadequate myocardial protection did not play a detrimental role regarding the results of the immediate groups. According to our general policy, almost 90% of the acute patients received an LITA graft to the left anterior descending artery. Although it has been suggested by other authors that in the acute situation arterial grafts may be avoided because of spastic reactions, we did not encounter hemodynamic problems caused by a compro-

Table 4. Multivariate Risk Model for Postoperative Continuous Venovenous Hemofiltration Variable Female sex Age Body mass Index 25–27 ⬍25 ⬎27 Urgency Elective Urgent Emergent MI Stability Stable Unstable Resuscitation Serum creatinine (mmol/L) 50 –110 111–300 ⬎300 Renal function Normal Compensated Terminal

Odds Ratio

95% Confidence Interval

p Value

3.818 1.058

(1.824 –7.994) (1.012–1.106)

⬍0.001 0.012

Reference 1.262 0.287

(0.421–3.782) (0.079 –1.040)

0.052 0.678 0.057

Reference 1.546 5.520 12.145

(0.424 –5.639) (1.816 –16.780) (4.919 –29.986)

0.000 0.510 0.003 ⬍0.001

Reference 14.333 12.900

(4.686 – 43.839) (2.896 –57.458)

⬍0.001 ⬍0.001 0.001

Reference 2.237 24.924

(0.739 – 6.689) (6.697–91.709)

⬍0.001 0.152 ⬍0.001

Reference 1.612 29.332

(0.554 – 4.691) (7.479 –115.040)

⬍0.001 0.381 ⬍0.001

MI ⫽ myocardial infarction.

Ann Thorac Surg 2002;74:102– 8

Fig 1. Mean Cleveland-Score and EuroSCORE ⫾ standard deviation of the four groups: myocardial infarction (MI), emergent, urgent, and elective procedures. *p ⬍ 0.05 versus urgent, elective; #p ⫽ 0.067 MI versus emergent.

mised initial blood flow to the left anterior descending artery in acute patients [21]. Because of the absence of problems and considering the superior long-term patency rate of LITA grafts, we believe that they should indeed be used particularly in the acute setting. The number of venous grafts was lower in the elective group than in the emergent cohorts. This is caused by our regimen of performing total arterial revascularizations in the elective patients whenever the coronary morphology and availability of adequate arterial conduits allow it. Half of the acute patients received an IABP. This policy is very much in concordance with other studies [8]. As we did not encounter any adverse effects of counterpulsation with regard to compromised blood flow of the intestinal or femoral arteries, we advocate a liberal use of IABP during acute revascularization. The necessity of CVVH reflected the severity of the hemodynamic situation of our immediately revascularized patients. However, prerenal failure occurred most often in MI patients, although a statistical difference from the emergent group was not observed. Fortunately, in only a minority of these patients, renal failure became permanent. As expected, the logistical regression analysis demonstrated that unstable preoperative conditions increased the odds for renal failure. However, female sex and age also had an influence on postoperative renal function, thereby contributing to the well-known facts that female and elderly patients represent a separate risk group in coronary surgical procedures [2]. The EM of the patients who were revascularized during ongoing MI was similar to the emergent patients without acute infarction. Acute MI therefore does not appear to be an independent predictor for early death [3]. In the literature, EM has often been found to be in the range of 10% to 20% in acutely revascularized cohorts independent from the presence of acute MI [4, 15]. In

ALBES ET AL ACUTE REVASCULARIZATION

107

contrast, the prognosis of patients suffering from acute MI and hemodynamic compromise is poor when treated conservatively. Early death has been reported to range from 25% to more than 50% [3, 6]. The rationale for a surgical intervention is therefore to save the life of the patient, although the risks are high. In contrast, isolated elective coronary artery bypass grafting exhibits an EM of 2% to 3% in many large studies, which was confirmed by our results [21]. The urgent group revealed a surprisingly good outcome in this study. None of these patients died early, and few patients required perioperative counterpulsation although all remaining factors were similar to those obtained in the elective group. Urgent patients obviously represent a subgroup with an exceptionally low risk. It can be hypothesized that cardiologists refer those patients, who are not in a critical state of myocardial ischemia but exhibit severe stenoses, for an urgent procedure. The surgeon on the other hand may be more alert than in a routine procedure, and finally, less waiting time under unclear condition at home may also play a favorable role. The hypothesis that the odds for early death significantly increase when a patient is hemodynamically unstable or is suffering from impaired renal function could be proven by our study. Also female sex and age increased the risks for an adverse outcome, which has been shown earlier [16]. Risk scores are a valuable tool to estimate the particular risks of patients undergoing cardiac surgical procedures [12, 22–24]. Both the Cleveland-Score and the EuroSCORE are easy to obtain as they comprise only 15 to 16 single paragraphs. Myocardial infarction adds to the risk score in the EuroSCORE although a differentiation between acute and subacute MI does not exist. In contrast, the Cleveland-Score does not itemize MI, but assigns a substantial amount of points for an emergency. Both scores did indeed disclose the particularly elevated risks of acute operation. However, the Cleveland-Score showed a trend to reflect the differences between both immediate groups statistically whereas the EuroSCORE failed to distinguish adequately. Although both analyzed immediate groups represent inhomogeneous cohorts, our results show that distinct differences exist and can be used to aim at specific factors in subsequent studies on a prospective basis. All patients in our study were operated on using extracorporeal circulation. Recent papers suggested that acute revascularization be performed off-pump, although the presently published numbers of patients are small [25]. However, in the future, this approach may become feasible in certain subgroups of stable patients who require immediate revascularization and exhibit contraindications for extracorporeal circulation [26]. For these stable patients a preoperative IABP can be an additional option, if ventricular function is substantially reduced [26]. Those patients can then be transferred into the urgency status, which showed a favorable outcome in our study. Although we did not yet find criteria that are in favor of such an

108

ALBES ET AL ACUTE REVASCULARIZATION

approach, identification of a respective subgroup may be an interesting topic for further studies. We conclude that revascularization during acute MI carries a considerable but acceptable risk to die early, which is not substantially higher than the risk of patients undergoing an emergent procedure without acute MI. Revascularization can be successfully accomplished using blood cardioplegia and intensified hemodynamic support. The use of the LITA is recommended considering the absence of acute detriments and the improved long-term results. However, an increased perioperative morbidity must be expected. Our current experience obtained under identical procedural characteristics in a relatively short period indicates that the current risk groups— elective, urgent, and emergent revascularization—find proper reflection in established score systems. However, an adjustment regarding the presence of acute MI may even improve the stratification properties.

References 1. Zahn R, Schiele R, Schnieder S, et al. Decreased hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. J Am Coll Cardiol 2000;36:2064–7. 2. Antoniucci D, Valenti R, Moschi G, et al. Sex-based differences in clinical, and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction. Am J Cardiol 2001;87:289–93. 3. Hochmann JS, Sleeper LA, White HD, et al. One-year survival following early revascularization for cardiogenic shock. JAMA 2001;285:190–2. 4. Reinecke H, Fetsch T, Roeder N, et al. Emergency coronary artery bypass grafting after failed coronary angioplasty: what has changed in a decade? Ann Thorac Surg 2000;70: 1997–2003. 5. Marso SP, Bhatt DL, Roe MT, et al. Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. Circulation 2000;102:2952– 8. 6. Park WM, Connery CP, Hochman JS, Tislon DM, Anagnosopoulos CE. Successful repair of myocardial free wall rupture after thrombolytic therapy for acute infarction. Ann Thorac Surg 2000;70:1345–9. 7. Loubeyre C, Morice MC, Berzin B, et al. Emergency coronary artery bypass surgery following coronary angioplasty and stenting: results of a French multicenter registry. Cathet Cardiovasc Interv 1999;47:441– 8. 8. Sanborn TA, Sleeper LA, Bates ER, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 2000;36:1123–9. 9. Vermes E, Mesguich M, Houel R, et al. Cardiac troponin I

Ann Thorac Surg 2002;74:102– 8

10.

11. 12.

13. 14. 15.

16.

17.

18. 19. 20. 21. 22. 23.

24.

25.

26.

release after open heart surgery: a marker of myocardial protection? Ann Thorac Surg 2000;70:2087–90. Carrier M, Pellerin M, Perrault LP, Solymoss BC, Pelletier LC. Troponin levels in patients with myocardial infarction after coronary artery bypass grafting. Ann Thorac Surg 2000; 69:435– 40. Nashef SAM, Roques F, Michel P, et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999;16:9–13. Higgins TL, Estefanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients. A clinical severity score. JAMA 1992;267:2344– 8. Califf RM. Introduction: evidence to practice in acute coronary syndromes. Am J Cardiol 2000;86:1M–3M. Boylan MJ, Lytle BW, Taylor PC, et al. Have PTCA failures requiring emergent bypass operation changed? Ann Thorac Surg 1995;59:283– 6. Hirose H, Amano A, Yoshida T, Sunami H, Takahashi A, Nagano N. Surgical management of unstable patients in the evolving phase of acute myocardial infarction. Ann Thorac Surg 2000;69:425– 8. Gardner SC, Grunwald GK, Rumsfeld JS, et al. Risk factors for intermediate-term survival after coronary artery bypass grafting. Ann Thorac Surg 2001;72:2033–7. Lazar HL, Jacobs AK, Aldea GS, Shapira OM, Lancaster D, Shemin RJ. Factors influencing mortality after emergency coronary artery bypass grafting for failed percutaneous transluminal coronary angioplasty. Ann Thorac Surg 1997; 64:1747–52. Geissler H, Ho¨ lzl P, Marohl S, et al. Risk stratification in heart surgery: comparison of six score systems. Eur J Cardiothorac Surg 2000;17:400– 6. Horvath KA, Parker MA, Frederiksen JW, Palmer AS, Fullerton DA. Postoperative troponin I results: insult or injury? Clin Cardiol 2000;23:731–3. Buckberg GD. Substrate enriched war blood cardioplegia reperfusion: an alternate view. Ann Thorac Surg 2000;69: 334–5. Naunheim KS, Barner HB, Fioere AC. Results of internal thoracic artery grafting over 15 years: single versus double grafts (update). Ann Thorac Surg 1992;3:716– 8. Immer F, Habicht J, Nessensohn K, et al. Prospective evaluation of 3 different risk stratification scores in cardiac surgery. Thorac Cardiovasc Surg 2000;48:134–9. Roques F, Nashef SAM, Gauducheau ME, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 10,030 patients. Eur J Cardiothoracic Surg 1999;15:816–23. Gabrielle F, Roques F, Michel P, et al. Is the Parsonnet’s score a good predictive score of mortality in adult cardiac surgery? Assessment by a French multicenter study. Eur J Cardiothorac Surg 1997;11:406–14. D’Ancona G, Karamanoukian H, Ricci M, Kawaguchi A, Bergsland J, Salerno T. Myocardial revascularisation on the beating heart after recent onset of acute myocardial infarction. Heart Surg Forum 2001;4:74–9. Kang N, Edwards M, Larbalestier R. Preoperative intraaortic balloon pumps in high-risk patients undergoing open heart surgery. Ann Thorac Surg 2001;72:54–7.